Torapsel

DB13057InvestigationalProtein Based Therapies

Torapsel has been used in trials studying the prevention of Ischemia Reperfusion Injury.

Also known as
42-89-GLYCOPROTEIN (HUMAN CLONE PMT21:PL85 P-SELECTIN GLYCOPROTEIN LIGAND-1) FUSION PROTEIN WITH IMMUNOGLOBULIN (HUMAN CONSTANT REGION) · Recombinant P-Selectin glycoprotein ligand
Code names
WAY-164339

Resolves to

What you can answer from here — as of October 05, 2023

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Torapsel, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account